Article info
Basic and translational research
Extended report
Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis
- Correspondence to Evangelia Yannaki, George Papanicolaou Hospital, Gene and Cell Therapy Center, Hematology Department–BMT Unit, Thessaloniki 57010, Greece; eyannaki{at}u.washington.edu
Citation
Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis
Publication history
- Accepted March 23, 2012
- First published May 14, 2012.
Online issue publication
July 13, 2023
Article Versions
- Previous version (13 July 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions